Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
- PMID: 20213822
- DOI: 10.1002/mds.22875
Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
Abstract
This study was carried out to evaluate progression in Parkinson's disease (PD) by analyzing time taken to transit from one Hoehn and Yahr (H&Y) stage to the next stage and to investigate the variables that would be associated with H&Y transition times using a large PD database that contained prospectively collected information. Data were obtained from the movement disorder database of the National Neuroscience Institute in Singapore. Kaplan-Meier (KM) survival analysis was adopted to investigate the time taken to progress through various H&Y stages. Cox regression analysis was used to examine the association between the baseline variables at the entry point of each H&Y stage and the progression to the next stage. A total of 695 patients (mean age: 65.2, male: 57.3%) were studied. Using KM analysis, the median time taken to transit from H&Y stage 1 to 2, 2 to 2.5, 2.5 to 3 were 20, 62, and 25 months, respectively; whereas the median time taken to progress from stage 3 to 4 and 4 to 5 were 24 and 26 months, respectively. Cox regression analysis revealed that older age-at-diagnosis, longer PD duration, and higher Unified Parkinson's Disease Rating Scale (UPDRS) motor scores at baseline were associated with a significantly faster progression through various H&Y stages. Gender and ethnicity were not associated with disease progression. In conclusion, H&Y transition time is a useful measure of disease progression in PD and may be utilized in clinical studies evaluating therapeutic interventions and prognostic factors in PD.
2010 Movement Disorder Society
Similar articles
-
Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times.Parkinsonism Relat Disord. 2011 Mar;17(3):194-7. doi: 10.1016/j.parkreldis.2010.11.010. Epub 2010 Dec 14. Parkinsonism Relat Disord. 2011. PMID: 21159539
-
Progression of motor impairment and disability in Parkinson disease: a population-based study.Neurology. 2005 Nov 8;65(9):1436-41. doi: 10.1212/01.wnl.0000183359.50822.f2. Neurology. 2005. PMID: 16275832
-
The clinically important difference on the unified Parkinson's disease rating scale.Arch Neurol. 2010 Jan;67(1):64-70. doi: 10.1001/archneurol.2009.295. Arch Neurol. 2010. PMID: 20065131
-
A cumulative genetic risk score predicts progression in Parkinson's disease.Mov Disord. 2016 Apr;31(4):487-90. doi: 10.1002/mds.26505. Epub 2016 Feb 8. Mov Disord. 2016. PMID: 26853697 Review.
-
The natural history of Parkinson's disease.J Neurol. 2006 Dec;253 Suppl 7:VII2-6. doi: 10.1007/s00415-006-7002-7. J Neurol. 2006. PMID: 17131223 Review.
Cited by
-
Differences in Home Health Nursing Care for Patients with Parkinson's Disease by Stage of Progress: Patients in Hoehn and Yahr Stages III, IV, and V.Parkinsons Dis. 2021 Feb 22;2021:8834998. doi: 10.1155/2021/8834998. eCollection 2021. Parkinsons Dis. 2021. PMID: 33688425 Free PMC article.
-
Predictors of Falls with Injuries in People with Parkinson's Disease.Mov Disord Clin Pract. 2022 Dec 25;10(2):258-268. doi: 10.1002/mdc3.13636. eCollection 2023 Feb. Mov Disord Clin Pract. 2022. PMID: 36825046 Free PMC article.
-
Evaluating the Cost-Effectiveness of an Early Detection of Parkinson's Disease through Innovative Technology.Eng Econ. 2017;62(2):180-196. doi: 10.1080/0013791X.2017.1294718. Epub 2017 Mar 22. Eng Econ. 2017. PMID: 30135608 Free PMC article.
-
Altered connectivity in the cognitive control-related prefrontal cortex in Parkinson's disease with rapid eye movement sleep behavior disorder.Brain Imaging Behav. 2023 Dec;17(6):702-714. doi: 10.1007/s11682-023-00796-0. Epub 2023 Sep 18. Brain Imaging Behav. 2023. PMID: 37721659
-
Economic Evaluations Comparing Deep Brain Stimulation to Best Medical Therapy for Movement Disorders: A Meta-Analysis.Pharmacoeconomics. 2024 Jan;42(1):41-68. doi: 10.1007/s40273-023-01318-y. Epub 2023 Sep 26. Pharmacoeconomics. 2024. PMID: 37751075
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical